ICD-10-CM Billable Code

M67.261

Synovial hypertrophy, not elsewhere classified, right lower leg

Clinical Classification Guidelines

Medical Intelligence & Overview

Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, which lines the joints and bursae. When this thickening occurs specifically in the right lower leg, it can lead to discomfort, swelling, and reduced mobility. This condition falls under the ICD-10 classification M67.261, indicating localized synovial hypertrophy that isn't classified elsewhere. Understanding this condition involves exploring its causes, symptoms, diagnostic processes, and treatment options.

Causes & Symptoms

Clinical Causes: Chronic joint inflammation due to conditions such as rheumatoid arthritis or psoriatic arthritis Repetitive strain or overuse injuries affecting the lower leg joints Previous trauma or injury to the knee or ankle region Infections that cause inflammation within the joint Degenerative joint diseases like osteoarthritis Underlying systemic inflammatory conditions

Key Symptoms: Swelling and puffiness in the affected area of the right lower leg Persistent pain or tenderness around the joint Stiffness, especially after periods of inactivity Decreased range of motion in the affected joint A sensation of warmth in the area Occasional fluid buildup in the joint (effusion)

Diagnostic & Treatment

Diagnosis Path: Ultrasound imaging to evaluate the soft tissues and detect synovial thickening Magnetic resonance imaging (MRI) for detailed visualization of joint structures and extent of hypertrophy X-rays to rule out degenerative bone changes and other calcifications

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to decrease inflammation and pain Physical therapy to improve joint function and strengthen surrounding muscles Corticosteroid injections directly into the affected joint for localized relief Lifestyle modifications such as rest and activity adjustments to prevent further stress In severe cases, surgical intervention may be necessary to remove hypertrophic synovial tissue or repair joint structures Addressing underlying causes, such as controlling systemic inflammatory conditions, to prevent recurrence

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M67.261 a billable ICD-10 code?
Yes, M67.261 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M67.261?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, right lower leg and any associated comorbidities for accurate reporting.

Cite this Clinical Reference